SCHEMBL6789240

SCHEMBL6789240

CCC(C)COc1ccc(N(C)CCC2(O)CCN(Cc3ccccc3)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
FAAH O00519 1/20 0.39
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
FFAR1 O14842 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
OPRL1 P41146 1/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
LMNA P02545 1/20 0.38
MMP1 P03956 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6783679 0.99 POLB (0.39) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL6784165 0.91 FAAH (0.47) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
Hydrochloric Acid SCHEMBL6780177 0.90 FAAH (0.46) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL6784119 0.88 MAPK1 (0.49) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
Hydrochloric Acid SCHEMBL6785569 0.87 MAPK1 (0.48) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL6783586 0.86 MMP1 (0.50) ALDH1A1MEN1KMT2AKDM4ENPC1
SCHEMBL6784583 0.86 FAAH (0.46) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL6784711 0.85 MMP1 (0.52) ALDH1A1MEN1KMT2AKDM4ENPC1
Hydrochloric Acid SCHEMBL6784819 0.85 MMP1 (0.49) ALDH1A1MEN1KMT2AKDM4ENPC1
SCHEMBL6783521 0.85 MMP1 (0.51) MEN1KMT2ACYP2D6TSHROPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710060-B2 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2004-03-23 US disclosed
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-12-12 US disclosed
EP-1182192-A1 4-HYDROXYPIPERIDINE DERIVATIVES HAVING ANTIARRHYTHMIC EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020188006-A1 4-hydroxypiperidine derivatives having antiarrhythmic activity SCN5A, RYR2, SCN1B ALDH1A1 416/4885SMN1; SMN2 524/4885MEN1 4123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.